title: Cross interaction of melanocortinergic and dopaminergic systems in neural modulation.
abstract: Melanocortinergic and dopaminergic systems are widely distributed in the CNS and have been established as a crucial regulatory component in diverse physiological functions. The pharmacology of both melanocortinergic and dopaminergic systems including their individual receptors, signaling mechanisms, agonists and antagonists has been extensively studied. Several lines of evidence showed that there existed a cross interaction between the receptors of melanocortinergic and dopaminergic systems. The data available at present had expanded our understanding of melanocortinergic and dopaminergic system interaction in neural modulation, which will be main discussed in this paper.
authors.affiliation: Department of Anesthesiology and Pain Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, Hubei, PR China.
authors.forename: Zhi-Gang
authors.initials: ZG
authors.lastname: He
authors.affiliation: Department of Anesthesiology and Pain Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, Hubei, PR China.
authors.forename: Bao-Wen
authors.initials: BW
authors.lastname: Liu
authors.affiliation: Department of Anesthesiology and Pain Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan 430030, Hubei, PR China.
authors.forename: Hong-Bing
authors.initials: HB
authors.lastname: Xiang
keywords: Melanocortinergic system; dopamine; dopaminergic system; receptor
references.citation: Neural Regen Res. 2012 Sep 25;7(27):2107-14
references.pmid: 25558223
references.citation: Int J Clin Exp Pathol. 2014 Jul 15;7(8):5348-54
references.pmid: 25197422
references.citation: Med Hypotheses. 2011 Dec;77(6):1135-8
references.pmid: 21978970
references.citation: J Comp Neurol. 2012 Dec 15;520(18):4168-83
references.pmid: 22605619
references.citation: Diabetes. 1997 Dec;46(12):2119-23
references.pmid: 9392508
references.citation: J Neurosci. 2006 Mar 8;26(10 ):2788-97
references.pmid: 16525058
references.citation: Endocrinology. 2014 May;155(5):1718-27
references.pmid: 24605830
references.citation: PLoS One. 2014 Feb 19;9(2):e89486
references.pmid: 24586817
references.citation: J Neurosci. 2003 Aug 6;23(18):7143-54
references.pmid: 12904474
references.citation: PLoS One. 2010 Dec 09;5(12):e15222
references.pmid: 21151605
references.citation: Int J Clin Exp Pathol. 2014 Jul 15;7(8):5343-7
references.pmid: 25197421
references.citation: Nutr Metab (Lond). 2007 Sep 01;4:18
references.pmid: 17764572
references.citation: J Huazhong Univ Sci Technolog Med Sci. 2013 Apr;33(2):195-8
references.pmid: 23592129
references.citation: Biochem Pharmacol. 2013 Oct 15;86(8):1181-93
references.pmid: 23876345
references.citation: Int J Clin Exp Pathol. 2014 May 15;7(6):2987-97
references.pmid: 25031717
references.citation: Neuron. 1999 Apr;22(4):743-50
references.pmid: 10230794
references.citation: Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):815-9
references.pmid: 12740128
references.citation: Mol Pharmacol. 1996 Sep;50(3):583-91
references.pmid: 8794897
references.citation: Physiol Behav. 2006 Nov 30;89(4):531-5
references.pmid: 16822531
references.citation: Nature. 2012 Jul 11;487(7406):183-9
references.pmid: 22785313
references.citation: Peptides. 2005 Oct;26(10):1952-64
references.pmid: 15979204
references.citation: Trends Neurosci. 2004 Oct;27(10):585-8
references.pmid: 15374668
references.citation: J Clin Invest. 2010 Aug;120(8):2745-54
references.pmid: 20628197
references.citation: Neuroscience. 2014 Dec 12;282:60-8
references.pmid: 24875175
references.citation: Trends Cogn Sci. 2011 Jan;15(1):37-46
references.pmid: 21109477
references.citation: Psychopharmacology (Berl). 2013 Mar;226(1):25-34
references.pmid: 23010797
references.citation: Genes Brain Behav. 2013 Aug;12(6):658-65
references.pmid: 23786641
references.citation: Philos Trans R Soc Lond B Biol Sci. 2006 Jul 29;361(1471):1149-58
references.pmid: 16874930
references.citation: Science. 2011 Jul 15;333(6040):353-7
references.pmid: 21764750
references.citation: Peptides. 2005 Oct;26(10):1733-43
references.pmid: 15978703
references.citation: Sci Transl Med. 2013 Oct 23;5(208):208ra146
references.pmid: 24154600
references.citation: J Neurosci. 2002 May 1;22(9):3306-11
references.pmid: 11978804
references.citation: Brain. 2013 Oct;136(Pt 10):e251
references.pmid: 23771341
references.citation: Eur J Neurosci. 2015 Nov;42(9):2699-706
references.pmid: 26354486
references.citation: Life Sci. 2003 Jul 4;73(7):823-47
references.pmid: 12798410
references.citation: Physiol Behav. 2012 May 15;106(2):201-10
references.pmid: 22342812
references.citation: Psychopharmacology (Berl). 2015 Jan;232(1):285-94
references.pmid: 24985892
references.citation: J Chem Neuroanat. 2010 Dec;40(4):310-24
references.pmid: 20884347
references.citation: Diabetes. 2006 Mar;55(3):567-73
references.pmid: 16505217
references.citation: Hypertension. 2011 Mar;57(3):375-6
references.pmid: 21263117
references.citation: Parkinsonism Relat Disord. 2014 Apr;20(4):468-70
references.pmid: 24508572
references.citation: Front Neuroanat. 2014 Mar 26;8:14
references.pmid: 24723856